(Q40750557)

23 September 2017

1 reference

title

Contraception for patients with psychiatric or medical disorders (English)

1 reference

23 September 2017

1 reference

Jones KP

1

1 reference

23 September 2017

Wild RA

series ordinal

2

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 May 1994

1 reference

American Journal of Obstetrics and Gynecology

23 September 2017

published in

1 reference

23 September 2017

volume

170

1 reference

23 September 2017

issue

5 Pt 2

1 reference

23 September 2017

page(s)

1575-1580

1 reference

Considerations for contraception in women with cardiovascular disorders

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2905022-2

Abdominal fat distribution and disease: an overview of epidemiological data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2905022-2

Oral contraceptive estrogen dose and the risk of deep venous thromboembolic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2905022-2

Contraception and dyslipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2905022-2

Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2905022-2

Clinical aspects of the relationship between oral contraceptives, abnormalities in carbohydrate metabolism, and the development of cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2905022-2

Incidence of thyroid disease associated with oral contraceptives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2905022-2

The WHO Collaborative Study of Neoplasia and Steroid Contraceptives: the influence of combined oral contraceptives on risk of neoplasms in developing and developed countries.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2905022-2

Oral contraceptives and pituitary adenomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2905022-2

Family planning needs of female chronic psychiatric outpatients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2905022-2

Use of oral contraceptives by women with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2905022-2

Treatment of seizures with medroxyprogesterone acetate: preliminary report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2905022-2

Contraceptive use in the chronically ill adolescent female: Part I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2905022-2

Contraceptive use in the chronically ill adolescent female. Part II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2905022-2

Interaction between anticoagulants and contraceptives: an unsuspected finding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2905022-2

10.1016/S0002-9378(94)05022-2

7 January 2021

Identifiers

DOI

1 reference

23 September 2017

1 reference